Notch signaling requires GATA-2 to inhibit myelopoiesis from embryonic stem cells and primary hemopoietic progenitors

被引:54
作者
de Pooter, Renee F.
Schmitt, Thomas M.
de la Pompa, Jose Luis
Fujiwara, Yuko
Orkin, Stuart H.
Zuniga-Pflucker, Juan Carlos
机构
[1] Univ Toronto, Sunnybrook & Womens Res Inst, Dept Immunol, Toronto, ON M4N 3M5, Canada
[2] Univ Autonoma Madrid, Consejo Super Invest Cientificas, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain
[3] Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Howard Hughes Med Inst, Boston, MA 02115 USA
关键词
D O I
10.4049/jimmunol.176.9.5267
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The bone marrow and thymus, although both hemopoietic environments, induce very distinct differentiation outcomes. The former supports hemopoietic stem cell self-renewal and multiple hemopoietic lineages, while the latter supports T lymphopoiesis almost exclusively. This distinction suggests that the thymic environment acts to restrict the hemopoietic fates available to thymic immigrants. In this study, we demonstrate that the addition of the Notch ligand Delta-like-1 (DII-1) to an in vitro system that otherwise supports myelopoiesis, greatly reduces the myelopoietic potential of stem cells or uncommitted progenitors. In contrast, committed myeloid progenitors mature regardless of the presence of DII-1. The block in myelopoiesis is the direct result of Notch signaling within the hemopoietic progenitor, and DII-1-induced signals cause a rapid increase in the expression of the zinc finger transcription factor GATA-2. Importantly, in the absence of GATA-2, DII-1-induced signals fail to inhibit commitment to the myeloid fate. Taken together, our results support a role for GATA-2 in allowing DII-1 to restrict non-T cell lineage differentiation outcomes.
引用
收藏
页码:5267 / 5275
页数:9
相关论文
共 76 条
  • [21] 2-E
  • [22] Differential response of primitive human CD34- and CD34+ hematopoietic cells to the Notch ligand Jagged-1
    Karanu, FN
    Yuefei, L
    Gallacher, L
    Sakano, S
    Bhatia, M
    [J]. LEUKEMIA, 2003, 17 (07) : 1366 - 1374
  • [23] Redefinition of lymphoid progenitors
    Katsura, Y
    [J]. NATURE REVIEWS IMMUNOLOGY, 2002, 2 (02) : 127 - 132
  • [24] Overexpression of the Notch target genes Hes in vivo induces lymphoid and myeloid alterations
    Kawamata, S
    Du, CC
    Li, KJ
    Lavau, C
    [J]. ONCOGENE, 2002, 21 (24) : 3855 - 3863
  • [25] Redirecting differentiation of hematopoietic progenitors by a transcription factor, GATA-2
    Kitajima, K
    Tanaka, M
    Zheng, J
    Yen, H
    Sato, A
    Sugiyama, D
    Umehara, H
    Sakai, E
    Nakano, T
    [J]. BLOOD, 2006, 107 (05) : 1857 - 1863
  • [26] KODAMA H, 1994, EXP HEMATOL, V22, P979
  • [27] Notch1 inhibits differentiation of hematopoietic cells by sustaining GATA-2 expression
    Kumano, K
    Chiba, S
    Shimizu, K
    Yamagata, T
    Hosoya, N
    Saito, T
    Takahashi, T
    Hamada, Y
    Hirai, H
    [J]. BLOOD, 2001, 98 (12) : 3283 - 3289
  • [28] The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1
    Li, LH
    Milner, LA
    Deng, Y
    Iwata, M
    Banta, A
    Graf, L
    Marcovina, S
    Friedman, C
    Trask, BJ
    Hood, L
    Torok-Storb, B
    [J]. IMMUNITY, 1998, 8 (01) : 43 - 55
  • [29] GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells
    Ling, KW
    Ottersbach, K
    van Hamburg, JP
    Oziemlak, A
    Tsai, FY
    Orkin, SH
    Ploemacher, R
    Hendricks, RW
    Dzierzak, E
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (07) : 871 - 882
  • [30] The soluble Notch ligand, Jagged-1, inhibits proliferation of CD34+ macrophage progenitors
    Masuya, M
    Katayama, N
    Hoshino, N
    Nishikawa, H
    Sakano, S
    Araki, H
    Mitani, H
    Suzuki, H
    Miyashita, H
    Kobayashi, K
    Nishii, K
    Minami, N
    Shiku, H
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (03) : 269 - 276